Hussman Strategic Advisors, Inc. / CN2
Hussman Strategic Advisors, Inc.’s Catalyst Pharmaceuticals Inc Position
Does Hussman Strategic Advisors, Inc. own Catalyst Pharmaceuticals Inc (CN2)? Yes — 84.0K shares worth $2M (+0.45% of its 13F portfolio) as of Q1 2026, down from 105.0K shares the prior filed quarter.
Position Value
$2M
Q1 2026
Shares
84.0K
% of Portfolio
+0.45%
Quarters Held
19
currently held
Position History CN2
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 84.0K | $2M | +0.45% |
| Q4 2025 | 105.0K | $2M | +0.59% |
| Q3 2025 | 147.0K | $3M | +0.63% |
| Q2 2025 | 147.0K | $3M | +0.73% |
| Q1 2025 | 84.0K | $2M | +0.49% |
| Q4 2024 | 105.0K | $2M | +0.65% |
| Q3 2024 | 105.0K | $2M | +0.51% |
| Q2 2024 | 105.0K | $2M | +0.45% |
| Q1 2024 | 105.0K | $2M | +0.39% |
| Q4 2023 | 157.5K | $3M | +0.60% |
| Q3 2023 | 157.5K | $2M | +0.35% |
| Q2 2023 | 93.0K | $1M | +0.23% |
| Q1 2023 | 93.0K | $2M | +0.24% |
| Q4 2022 | 62.0K | $1M | +0.19% |
| Q3 2022 | 62.0K | $795,000 | +0.14% |
| Q1 2022 | 68.0K | $564,000 | +0.11% |
| Q4 2021 | 68.0K | $460,000 | +0.10% |
| Q3 2021 | 124.0K | $657,000 | +0.14% |
| Q2 2021 | 124.0K | $713,000 | +0.15% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hussman Strategic Advisors, Inc.’s full portfolio or all institutional holders of CN2.